Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
University College London Hospitals NHS Foundation Trust
Genentech
EMD Serono
Sanofi Genzyme
Health Technology Assessment Programme
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
Basil Sharrack, Stefano Pluchino, James Blackstone, Nikos Evangelou et al.
Citations
17 citations
Journal
BMJ Open
Topics
Multiple Sclerosis Research Studies
Field-Weighted Citation Impact (FWCI)
7.22
article
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
Basil Sharrack, Stefano Pluchino, James Blackstone, Nikos Evangelou, Fayyaz Ahmed, Jeremy Chataway, Jeremy Hobart, Anisha Doshi, Gavin Giovannoni, Suresh Kumar Chhetri, Nevin John, Agne Straukiene, Sean Apap Mangion, Owen Pearson, Sreedharan Harikrishnan, Sue Pavitt, Thomas Williams, Judy Beveridge, Gil Barton, Paul W. Gallagher, Ian Galea, Ruth Geraldes, David Rog, Cord Spilker, Floriana De Angelis, Marie Braisher, Timothy Harrower, Ekaterina Bordea, Claire M Rice, Annie Hawton, Charles E. Wade, Tarunya Arun, Rachael Hunter, Siddharthan Chandran, John Greenwood, Don Mahad, Eli Silber, Alan J. Thompson, Rachel Merry, Olga Ciccarelli, Alberto Calvi, Helen Ford, Martin L. Lee, Susan Tebbs, Craig Hillier, Stuart J Nixon, Alessia Bianchi, Jeban Ganesalingam, Chris Frost, Abdullah Shehu, Martin Duddy, Miriam Mattoscio, Carolyn Young, Nicholas Richard, Seema Kalra, Dawn Lyle, Elisabeth Jarman, Leonora Fisniku, Neil Robertson, Matthew Craner, Jennifer Nicholas, Gavin McDonnell
article en
17 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(9)
Institutions
Belfast Health and Social Care Trust (GB), Barking, Havering And Redbridge University Hospitals NHS Trust (GB), Lancashire Teaching Hospitals NHS Foundation Trust (GB), Swansea Bay University Health Board (GB), Leeds General Infirmary (GB), North Bristol NHS Trust (GB), University of Leeds (GB), NHS Lothian (GB), Nottingham University Hospitals NHS Trust (GB), University of Ulster (GB), University of Liverpool (GB), Imperial College Healthcare NHS Trust (GB), Queen Mary University of London (GB), University of Hull (GB), University of Exeter (GB), University of Cambridge (GB), Royal Devon & Exeter NHS Foundation Trust (GB), University Hospitals of North Midlands NHS Trust (GB), Norfolk and Norwich University Hospitals NHS Foundation Trust (GB), University Hospital of Wales (GB), Poole Hospital (GB), Salford Royal NHS Foundation Trust (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Multiple Sclerosis Society (GB), Cambridge University Hospitals NHS Foundation Trust (GB), University Hospitals Coventry and Warwickshire NHS Trust (GB), East Kent Hospitals University NHS Foundation Trust (GB), Belfast City Hospital (GB), Walton Centre (GB), University Hospital Southampton NHS Foundation Trust (GB), National Institute for Health and Care Research (GB), London School of Hygiene & Tropical Medicine (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), Oxford University Hospitals NHS Trust (GB), University Hospitals Sussex NHS Foundation Trust (GB), National Hospital for Neurology and Neurosurgery (GB), Torbay and South Devon NHS Foundation Trust (GB), Queen Elizabeth University Hospital (GB), Lewisham and Greenwich NHS Trust (GB), Bradford Teaching Hospitals NHS Foundation Trust (GB), University Hospitals Plymouth NHS Trust (GB), University of Southampton (GB), University Hospitals Dorset NHS Foundation Trust, University College London (GB), University of Edinburgh (GB)
Funders
GlaxoSmithKline, Sanofi, Biogen, Teva Pharmaceutical Industries, Celgene, Merck KGaA, Moderna, National Institute for Health and Care Research, Multiple Sclerosis Society, University College London, Rosetrees Trust, University College London Hospitals NHS Foundation Trust, Genentech, EMD Serono, Sanofi Genzyme, Health Technology Assessment Programme